Medtronic Minimed, Inc.

This study tested a smart insulin pen and continuous glucose monitor system (Smart MDI) against standard insulin injections with glucose monitoring in 179 people with type 1 diabetes. The goal was to see if the smart system helps keep blood sugar in a healthy range more effective…

This study tested the safety of the MiniMed 780G insulin pump paired with the DS5 continuous glucose monitor in 56 children aged 2-6 with type 1 diabetes. The children used the system at home, and researchers tracked how often their blood sugar stayed in a healthy range, as well …

This study tested the MiniMed 780G system, an automated insulin pump, in 574 adults with type 2 diabetes who need insulin. Participants used the pump at home for about 135 days. The goal was to see if the system safely improves blood sugar levels and time in range. Results help s…